Jeremiah Helm Comments On How Upcoming Supreme Court ‘Skinny Label’ Case Could Impact Hatch-Waxman Litigation
In interviews with Law360 and Life Sciences Intellectual Property Review, Knobbe Martens partner Jeremiah Helm offered insights into the Supreme Court’s decision to hear a petition of the Federal Circuit’s...
Jeremiah Helm Quoted on Supreme Court’s Skinny Label Patent Infringement Decision in Hikma v. Amarin
Knobbe Martens partner Jeremiah Helm was quoted by Bloomberg Law, Law360, and MLex on the U.S. Supreme Court’s unanimous ruling in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., which...
Jeremiah Helm Shares Post-Argument Insights on Supreme Court “Skinny Label” Patent Infringement Case, Hikma v. Amarin
Following April 29 oral arguments in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., the closely watched Supreme Court case on whether a generic drug manufacturer can be held liable...